The global organ transplant market is projected to grow at a CAGR of 2.19% to reach a market size of USD59.577 billion by 2024. Organ transplants are also known as grafts where a complete organ or a section of the healthy organ from its original site is transferred to the area of interest in a different individual. Thus, the transplanted organ or graft continue to receive nourishment from the new and healthy environment. Prevalence of chronic diseases is one of the major factors driving the growth of the global organ transplant market in the forecast period. Furthermore, growing health awareness along with government initiatives regarding organ donation is driving the market growth. However, the shortage of organ donors and incidences of transplant rejection may impede the growth of the global organ transplant market during the forecast period. Additionally, technological advancements will drive market growth in the forecast period and in the upcoming years.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the organ transplant value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global organ transplant market.
Major industry players profiled as part of the report are Transplant Biomedicals, Sandor, Veloxis Pharmaceuticals, Inc., Bridge to Life Ltd., Paragonix Technologies Inc., Global Transplant Solutions, XVIVO Perfusion, Organ Recovery Systems, and Pure Transplant Solutions, LLC.
The global organ transplant market has been analyzed through following segments:
By Organ Type
By Type of Organ Donors
Organ Transport Systems
Middle East and Africa
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Force Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. GLOBAL ORGAN TRANSPLANTMARKET BY ORGAN TYPE
6. GLOBAL ORGAN TRANSPLANT MARKET BY TYPE OF ORGAN DONORS
6.1 Living Donors
6.2. Deceased Donors
7. GLOBAL ORGAN TRANSPLANT MARKET BY PRODUCT
7.1. Immunosuppresive drugs
7.2. Preservation Solutions
7.3. Organ Transport Systems
8. GLOBAL ORGAN TRANSPLANT MARKET BY GEOGRAPHY
8.1. North America
8.2. South America
8.3.3. United Kingdom
8.4. Middle East and Africa
8.4.1. Saudi Arabia
8.5. Asia Pacific
8.5.3. South Korea
9. COMPETITIVE INTELLIGENCE
9.1. Competitive Benchmarking and Analysis
9.2. Recent Investment and Deals
9.3. Strategies of Key Players
10. COMPANY PROFILES
10.1. Transplant Biomedicals
10.3. Veloxis Pharmaceuticals, Inc.
10.4. Bridge to Life Ltd.
10.5. Paragonix Technologies Inc.
10.6. Global Transplant Solutions
10.7. XVIVO Perfusion
10.8. Organ Recovery Systems
10.9. Pure Transplant Solutions, LLC
LIST OF FIGURES
LIST OF TABLES
Veloxis Pharmaceuticals, Inc.
Bridge to Life Ltd.
Paragonix Technologies Inc.
Global Transplant Solutions
Organ Recovery Systems
Pure Transplant Solutions, LLC
All our studies come with 2 months of analyst support.
We are in compliance with the global privacy laws.